Viral Vector Services

AAV Vector Upstream Processes

We assist with selecting the producer cell line and culture type based on the AAV serotype and other factors and needs.


Our optimized E. coli processes produce high-quality AAV plasmids for transfection

The AAV vector upstream processes include:

  • Mammalian cell culture, e.g., HEK293, or Sf9 insect cells
  • Transfection with plasmids or transduction with baculovirus, depending on the selected approach and serotype
  • Cell harvest and lysis
  • Analysis of harvest

Suspension cell culture

Suspension cultures can be readily upscaled, as the limiting factor for cell growth is the concentration of cells in the medium. Suspension cells can be cultured in serum-free media, therefore free from bovine-derived impurities such as TSE and BSE. 

  • Shake flasks, capacity options 24 mL-5L
  • Single-use stirred-tank bioreactor up to 10 L
  • Wave bioreactor 25 L
  • Chemical lysis and clarification using depth filtration and microbial reduction filtration
  • Shake flasks, capacity options 24 mL-5L
  • Suspension bioreactor scale 10-200 L
  • Chemical lysis and clarification using depth filtration and microbial reduction filtration

Adherent cell culture

Adherent cell culture applies to most cell types. Some AAV vector constructs only produce good yields in adherent cultures. Growth monitoring of adherent cell cultures can be carried out visually under the microscope. Adherent cell growth is limited by surface area, which may limit product yields.

  • Cell factories
  • T-flasks
  • Hyperflasks
  • Cell stacks
  • Single-use stirred-tank bioreactor up to 10 L
  • Wave bioreactor 25 L
  • Packed-bed bioreactor up to 4 m2
  • Mechanic or chemical detaching/lysis of cells
  • Cell factories
  • T-flasks
  • Hyperflasks
  • Cell stacks
  • Single-use stirred-tank bioreactor up to 200 L
  • Wave bioreactor 25 L
  • Packed-bed bioreactor up to 500 m2
  • Mechanic or chemical detaching/lysis of cells

With you all the way…

together, making advanced biologics, and tomorrow’s life-transforming therapies.

We deliver unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substances and Drug Products, from pre-clinical to clinical development and commercial phases.

We support our customers wherever they are on their journey, from early-stage development to commercialization. We are passionate, precise, and always close, together, making advanced biologics and tomorrow’s life-transforming therapies.


Pre-Clinical

Phase I

Phase II

Phase III

Commercial